Indicated for: dry cough
Substance: butamirat (expectorant)
ATC: R05DB13 (Respiratory system | Cough suppressants, excl. combinations with expectorants | Other cough suppressants)
Butamiratum is a medication used for the treatment of dry, non-productive cough. It acts as a central antitussive, inhibiting the cough reflex at the central nervous system level without causing dependency.
The medication is taken orally, in the form of syrup or tablets, as directed by a doctor. The dosage is adjusted based on the patient's age and weight.
Common side effects include drowsiness, dizziness, and nausea. In rare cases, allergic reactions such as skin rashes or breathing difficulties may occur.
Butamiratum is not recommended for pregnant women during the first trimester or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about any other medications being used to avoid drug interactions.